Business Wire

Corporate Reputations Improve During a Year of Crises according to The RepTrak Company

12.4.2021 12:00:00 EEST | Business Wire | Press release

Share

The RepTrak Company™, the world’s leading reputation data and insights company, announces the results of the 2021 Global RepTrak® 100. The report is the world’s most comprehensive reputation study, compiled for the past 11 years using RepTrak’s in-depth analysis and ranking of the top 100 companies worldwide by Reputation Score.

In 2021, RepTrak found that, overall, it was a much more difficult year to break into the top 100. The average score (on a scale of 1-100) was almost 75, the highest in 11 years. This is an indication of the rigorous reputation management in place among these leaders. Several of the companies that rank highest in the 2021 Global RepTrak 100 are those that have implemented ESG (Environment, Societal impact and Governance) initiatives within their global strategies.

Notable findings include:

  • Being relevant mattered in a difficult year. Consumer durables and apparel, technology (both hardware and software) and household and personal products companies lead the way after a year when the world depended on them for productivity, entertainment, comfort and safety.
  • Pharmaceutical industry’s Reputation Score improved from “average” to “strong” with vaccines propelling positive perceptions. Sanofi S.A., Eli Lilly Company and Bristol Myers Squibb are among the top 10 for Reputation Score growth this year.
  • ESG leadership went to the pharmaceutical and household and personal products industries. The global respondents credited their ESG initiatives more than any other industries, another indication of the importance of pandemic-centered relevance in 2020.
  • GenZ (18-25) and Millennial (26-40) perceptions differ. GenZ perceives corporations with the greatest skepticism, as indicated by their weaker levels of support for the seven drivers of corporate reputation codified by RepTrak. Millennials were the most positive of all generational segments. GenX (41-55) and Boomers (56-64) fall in the middle and don’t differ greatly.

For the complete 2021 Global RepTrak 100 ranking and report, with comprehensive analysis of global, industry, and demographic trends, visit https://www.reptrak.com/rankings/

2021’s Reputation Leaders

The top 10 companies by Reputation Score, as ranked in the 2021 Global RepTrak® 100, are:

  1. The Lego Group
  2. Rolex SA
  3. Ferrari N.V.
  4. The Bosch Group
  5. Harley-Davidson, Inc.
  6. Canon Inc.
  7. adidas AG
  8. The Walt Disney Company
  9. Microsoft Corp.
  10. Sony Group Corp.

The Lego Group maintains its #1 ranking, showing a steady increase in Reputation Score over the last several years, with all others in the top 10 in a new position compared to last year’s report. These year over year changes indicate that a company must continually work to improve its reputation and stay relevant.

High Growth in a Challenging Year

The top ten (10) of the 100 companies rated by greatest reputation increases and positive movement in their ranking are: Unilever PLC; Mars, Incorporated; Cisco Systems, Inc.; The Samsung Group; Sanofi S.A.; Harley-Davidson, Inc.; HP Inc.; Procter & Gamble Company; Eli Lilly and Company; and Bristol Myers Squibb.

“At Cisco, we take our reputation seriously. Our purpose as a company is to power an inclusive future for all, and this drives everything we do. We believe it starts with the trust of our stakeholders to look after our people, our communities and our planet. This goes hand in hand with our relentless focus on innovation, to provide more choice and opportunities for our customers. The last year has been difficult for many, so it’s truly inspiring to be recognized for the impact we are making, and spurs us onwards to do more,” shared Gerri Elliot, EVP and Chief Sales and Marketing Officer at Cisco Systems, Inc.

“For Mars, building trust is a key business metric,” said Andy Pharoah, Vice President of Corporate Affairs & Sustainability at Mars, Incorporated, “And we believe maintaining a strong reputation is central to our ability to achieve our goals and live up to our purpose – that the world we want tomorrow starts with how we do business today. In the past year, which has been unlike any other, it’s more important than ever for businesses like Mars to communicate regularly and frequently with our stakeholders and Associates. Success is about navigating the challenges of the day with clarity, empathy and integrity. These results demonstrate that our efforts are having a positive impact, and are being recognized more broadly.”

Eighteen (18) companies are new to the Global RepTrak this year, the largest number of newcomers in the Global RepTrak 100 since its inception 11 years ago. These new entrants include luxury fashion leaders (Chanel Inc, Hermès, Prada Group, Burberry Group Plc), travel and automotive industry names (Volvo Group, Booking.com, Continental AG), consumer companies (Costco Wholesale Corporation, ALDI GmbH & Co. KG, Mattel, Inc.) and other leaders: Space Exploration Technologies Corp. (SpaceX), BIC, Adobe Systems, Hewlett Packard Enterprise, PayPal, Henkel AG & Co.

ESG rises in importance

ESG stands for Environmental, Social impact and Governance issues. The Global RepTrak 100 results clearly show that there is a strong correlation between companies that adhere to high ESG standards and companies that score favorably on the 2021 Global RepTrak 100.

“ESG is being used for the first time this year as a measurable component of reputation, and we can see firsthand why this is so important for 2021 and beyond. There is a strong correlation between companies who hold themselves to high standards, and companies who rank highly on the 2021 Global RepTrak® 100,” says Kylie Wright-Ford, CEO of The RepTrak Company. “Stakeholders have access to more information than ever before, which is empowering them to make more informed decisions. Companies must not only deliver a quality product, but also show that they are doing so in an ethical and globally considerate way.”

RepTrak is the only provider of data and insights around ESG perception at a global scale. For Environment, RepTrak looks at how companies are perceived with regard to climate change, the use of resources and the minimization of its carbon footprint. Social investigates perceptions of how companies lead on human rights, their participation in their local communities and how they handle employees and customers. Governance relates to the leadership, ethics and rights of shareholders and other stakeholders.

Report and Methodology

RepTrak helps companies understand how stakeholders feel, think, and act towards them, measuring reputation using a 0-100 scale and tracking how a company is perceived across several reputation drivers: Products & Services, Innovation, Citizenship, Performance, Governance, Leadership and Workplace. RepTrak’s proprietary measurement system has been developed to allow worldwide application on a normative scale, which enables direct comparison regardless of sector, size, or geography.

For consideration in the 2021 Global RepTrak® 100, a company had to meet the following criteria:

  • Be a corporate brand with global revenue above USD $2 billion
  • Achieve a global average familiarity threshold above 20 percent in all fifteen countries measured and a familiarity threshold above 20 percent in eight or more of the fifteen countries measured
  • Reach a qualifying Reputation Score above the median score (i.e., 67.3 points)

To determine the ranking, The RepTrak Company analyzed reputation data for several thousand companies which was collected between December 2020 and January 2021 using world class survey methodology and was enriched by RepTrak’s historical database. Companies that met these criteria were then ranked based on their global Reputation Scores. A company’s corporate reputation is determined using RepTrak’s proprietary and patent-pending Reputation Score - a score from 0-100 that measures how people feel towards a particular company. Reputation Scores demonstrate a strong positive relationship with business outcomes, such as an audience’s willingness to buy, recommend, or trust a company. The top 100 companies with the highest Reputation Scores made the final ranking.

The Global RepTrak® 100 ranking is based on 68,577 respondents collected across the 15 largest economies globally using online surveys. For access to the report, visit https://www.reptrak.com/rankings/

About RepTrak

The RepTrak Company™ is the world’s leading reputation data and insights company. We provide the only global platform for data-driven insights on Reputation, Brand, and ESG. Our proprietary RepTrak® model is the global standard for measuring and analyzing the sentiment of the world using proven data science models and machine learning techniques across industries and geographies.

Subscribers to the RepTrak® Program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society.

Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database of over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit www.reptrak.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PR Contact: Amanda Donnelly / PR Hacker / RepTrak@PRHacker.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK ® and TRIKAFTA ® , Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 14:30:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported by clinical and/or in vitro data from 564 variants demonstrating response to ALYFTREK and 521 variants demonstrating response to TRIKAFTA. As such, approximately 800 more people with a clinical diagnosis of CF in the U.S. are now eligible for a medicine that treats the underlying cause of their disease for the first time. This extension means approxim

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 14:30:00 EEST | Press release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooperative networks of CCTG, GI Cancer Trials in Australia and France’s Partenariat de Recherche en Oncologie Digestive (PRODIGE) consortium (including Unicancer, GERCOR and FFCD). The BATTMAN (CO.33) trial serves as the registrational-enablin

Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 14:19:00 EEST | Press release

Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user

Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 14:00:00 EEST | Press release

Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 14:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye